Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer: The PRONOUNCE Trial Study Design

OBJECTIVES: This study will compare the incidence of major adverse cardiovascular events (MACEs) with androgen deprivation therapy (ADT) among men with advanced prostate cancer who are being treated with a gonadotropin-releasing hormone (GnRH) antagonist versus a GnRH agonist. BACKGROUND: Treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Melloni, Chiara, Slovin, Susan F., Blemings, Allan, Goodman, Shaun G., Evans, Christopher P., Nilsson, Jan, Bhatt, Deepak L., Zubovskiy, Konstantin, Olesen, Tine K., Dugi, Klaus, Clarke, Noel W., Higano, Celestia S., Roe, Matthew T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352040/
https://www.ncbi.nlm.nih.gov/pubmed/34396210
http://dx.doi.org/10.1016/j.jaccao.2020.01.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352040/
https://www.ncbi.nlm.nih.gov/pubmed/34396210
http://dx.doi.org/10.1016/j.jaccao.2020.01.004

Ejemplares similares